Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.160
+0.090 (4.35%)
At close: Aug 14, 2026, 4:00 PM EDT
2.200
+0.040 (1.85%)
After-hours: Aug 14, 2026, 7:43 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $45.44 million as of August 14, 2026. Its market cap has increased by 2.34% in one year.
Market Cap
45.44M
Enterprise Value
31.68M
1-Year Change
2.34%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $45.44M, a decrease of -99.33%. That is a compound annual growth rate of -35.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 33.70M | -31.08% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 47.66M |
| Seres Therapeutics | 46.92M |
| CervoMed | 46.42M |
| Karyopharm Therapeutics | 46.01M |
| Metagenomi Therapeutics | 45.93M |
| Filana Therapeutics | 45.09M |
| Veru Inc. | 43.98M |
| Aligos Therapeutics | 43.71M |